China National Pharmaceutical Group and Longsha Group signed a joint venture extension agreement for Suzhou Capsule Co., Ltd.

On May 16, the signing ceremony for the renewal of the 20-year partnership between China National Pharmaceutical Group and Switzerland Lonza Group's joint venture Suzhou Capsule Co., Ltd. was held at the Suzhou Industrial Park. Jean-Christophe Wyss, President of Lonza Group's Capsule and Nutritional Ingredients Division, expressed his expectation that Lonza Group and China National Pharmaceutical Group will continue to cooperate sincerely in the next twenty years and better serve global patients. Lonza Group will also continue to increase its investment in China, constantly introducing new products and technologies to promote the healthy development of the joint venture company.